CFO Dive

Johnson & Johnson CFO taps internal investment for medtech growth

The pharma company is on track to reach $100 billion in recorded revenue despite “temporary” headwinds in its medtech segment, executives said.

By CFO Dive

1 min read
Johnson & Johnson CFO taps internal investment for medtech growth
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Business Operations

Related Insights